Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More
October 14, 2024 11:15 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Peptide...
Lipid Nanoparticles Market Research 2024 - Global Forecast to 2029: Increasing Use of Lipid Nanoparticles in Anti-Cancer Research and Growing Demand for Advanced Drug Delivery Systems
October 07, 2024 11:52 ET
|
Research and Markets
Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "Lipid Nanoparticles Market by Product (Ionizable Lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (SiRNA, MRNA), Application,...
Lipid Nanoparticles for Gene Therapy Market Research 2024: Gene Therapy Sales are Projected to Exceed $10bn by 2027 - LNPs have Gained Popularity as Carriers for Gene Therapies
September 18, 2024 09:05 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Gene therapy - Lipid nanoparticles" report has been added to ResearchAndMarkets.com's offering.This report discusses the developing trend and...
Polymeric Nanoparticles Strategic Business Report 2023-2024 & 2030 - Growing Interest in Non-Toxic and Biodegradable Nanoparticles Bodes Well for Market Growth
September 17, 2024 07:44 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Polymeric Nanoparticles - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Polymeric...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candi-date Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against
Polymer Nanocomposites Strategic Business Report 2024-2030: Revolutionizing Material Science with Nano-Innovations
September 06, 2024 07:27 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Polymer Nanocomposites - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Polymer...
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
Metal and Metal Oxide Nanoparticle Market Report 2024-2030, Featuring American Elements, Nanoshell, Meliorum Technologies, EPRUI Nanoparticles & Microspheres, NanoScale and Reinste Nanoventures
August 13, 2024 10:00 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Metal and Metal Oxide Nanoparticle Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...